(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Docs 

Focuses on recent developments in biotechnology and pharmaceutical patent law, offering updates regarding changes in Patent Office rules and procedures that affect biotech/pharma patent prosecution, providing summaries of recent court decisions that impact biotech/pharma patent litigation and prosecution, and monitoring newly filed biotech/pharma patent litigation. In addition, Patent Docs highlights recently issued biotech/pharma patents, and reports on biotech/pharma news.
Post Frequency: 20.5/day Last Entry: April 01, 2011 at 01:59:00 Recent Entries: 1661
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
Go to Patent Docs, find other Patent Law blogs, or browse all law blogs.
FierceBiotech Announces the "Fierce 15" Biotech Companies for 2008
Posted on June 26, 2008By Christopher P. Singer -- On Monday, FierceBiotech published its annual "Fierce 15" list of what it considers to be among the most promising of the up-and-coming companies in the biotechnology industry. FierceBiotech, a daily biotech industry news provider, has been publishing the Fierce 15 since 2003...
An Analysis of the New Written Description Training Materials ? Protein Variants
Posted on June 25, 2008By Christopher P. Singer -- In April, the U.S. Patent and Trademark Office announced that it had updated the training materials to be used by examiners in the examination of patent applications for compliance with the written description requirement of 35 U...
Patent Profile: Chemokine Therapeutics Announces Issuance of Two Patents for Chemokine-Based Therapies
Posted on June 25, 2008By Kwame Mensah -- Last month, Chemokine Therapeutics Corp. announced that it has been granted U.S. Patent Nos. 7,354,899, entitled "Methods of treating Autoimmune Diseases Comprising Administering CXCR4 Antagonists" and 7,368,425, entitled "Cyclic Peptides for Modulating Growth of Neo-Vessels and Their Use in Therapeutic Angiogenesis...
Docs at BIO: Panel Discusses Impact of USPTO Rules Changes and Patent Reform Legislation on Biotech Patenting
Posted on June 24, 2008By Donald Zuhn -- Last Thursday, a diverse panel comprising both in-house and outside counsel and both corporate and venture capital interests participated in a breakout session at the BIO International Convention to discuss IP challenges and strategies for biotech and pharma companies as a result of pending USPTO rules changes and possible patent reform legislation...
Court Report
Posted on June 22, 2008By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Jassen, L.P. et al. v. KV Pharmaceutical Co. 3:08-cv-03012; filed June 17, 2008 in the District Court of New Jersey Infringement of U...
Conference & CLE Calendar
Posted on June 22, 2008June 23, 2008 - Multilateral Patents (Law Seminars International) - San Francisco, CA July 1, 2008 - Prior Art & Obviousness 2008: The PTO and CAFC Perspective on Patent Law Sections 102 & 103 (Practising Law Institute) - New York, NY July 9-11, 2008 - Fundamentals of Patent Prosecution 2008: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) - San Francisco, CA July 16, 2008 - Patent Claim Construction Workshop (Law Seminars International) - Seattle, WA July 24-25, 2008 - Advanced Patent Prosecution Workshop 2008: Claim Drafting & Amendment Writing (Practising Law Institute) - New York,...
ACI Maximizing Pharmaceutical Patent Lifecycles Conference
Posted on June 21, 2008American Conference Institute (ACI) will be holding its 9th Annual Maximizing Pharmaceutical Patent Lifecycles conference on October 15-16, 2008 in New York. At the conference, ACI's faculty will offer presentations on the following topics: ? Clarifying the evolving meaning of 'patent life cycle' for the pharmaceutical business; ? Constructing, adjusting, and executing a pharmaceutical patent life cycle management plan; ? View for the FTC; ? Navigating the complexity of structuring patent settlement options between brand name and generic pharmaceutical patent cases; ? Eye on the bench: Identifying judicial trends in pharmaceutical patent cases; ? Mastering the intricacies of the 180-day...
USPTO News: USPTO Announces Proposed Additional Fee Increases for PCT Applications Filed with US/RO
Posted on June 19, 2008By Christopher P. Singer -- As we reported on Tuesday, the Patent Cooperation Treaty (PCT) has published an amended fee schedule for application filings that is due to take effect on July 1, 2008. In a Federal Register Notice that was published on Wednesday, June 18, 2008, the U...
Steve Burrill's State of the Biotechnology Industry Report 2008 at BIO
Posted on June 19, 2008By Kevin E. Noonan -- Steven Burrill, President and CEO of Burrill & Co., unveiled his company's "State of the Biotechnology Industry" report on Wednesday at BIO 2008 in San Diego. Mr. Burrill (below) described developments globally that he anticipates will occur by 2020 and how those changes will impact the industry...
Changes to PCT Filing Fees
Posted on June 17, 2008By Christopher P. Singer -- The Patent Cooperation Treaty (PCT) recently published a Notification (No. 189) describing an amended fee schedule which will take effect on July 1, 2008. The new fee schedule modifies the international filing fee as well as the fee reductions for applicants who file electronically...
What the Director's Letter Didn't Say
Posted on June 16, 2008By Kevin E. Noonan -- As reported by Patent Docs last week, U.S. Patent and Trademark Office Director Jon Dudas (at right) responded to Congressman Howard Berman's (D-CA) April letter posing a number of questions raised by Director Dudas' February testimony before the House Subcommittee on Courts, the Internet and Intellectual Property...
Court Report
Posted on June 16, 2008By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Sepracor Inc. et al. v. Sandoz, Inc. 4:08-cv-00089; filed June 12, 2008 in the Eastern District of North Carolina Infringement of U...
Conference & CLE Calendar
Posted on June 16, 2008June 16, 2008 - Prior Art & Obviousness 2008: The PTO and CAFC Perspective on Patent Law Sections 102 & 103 (Practising Law Institute) - San Francisco, CA June 17-20, 2008 - BIO International Convention (Biotechnology Industry Organization) - San Diego, CA June 18-20, 2008 - Fundamentals of Patent Prosecution 2008: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) - New York, NY June 23, 2008 - Multilateral Patents (Law Seminars International) - San Francisco, CA July 1, 2008 - Prior Art & Obviousness 2008: The PTO and CAFC Perspective on Patent Law Sections 102 &...
PLI Patent Litigation 2008
Posted on June 14, 2008Practising Law Institute (PLI) will be holding five sessions of its Patent Litigation 2008 seminar this fall in San Francisco (September 22-23), McLean, VA (October 6-7), Chicago (October 23-24), Atlanta (November 10-11), and New York (November 17-18)...
Director Answers House Subcommittee's Questions
Posted on June 13, 2008By Donald Zuhn -- In February, the House Subcommittee on Courts, the Internet, and Intellectual Property held an oversight hearing on the U.S. Patent and Trademark Office. The Subcommittee heard statements from Jon Dudas, the Undersecretary of Commerce for Intellectual Property and Director of U...
Briefs for In re Kubin filed by Amgen and BIO
Posted on June 13, 2008By Kevin E. Noonan -- Amgen Inc., the real party in interest, and the Biotechnology Industry Organization filed briefs recently asking the Federal Circuit to overturn the decision by the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences in Ex parte Kubin (see Patent Docs post)...
In re Omeprazole Patent Litigation (Fed. Cir. 2008)
Posted on June 12, 2008By Donald Zuhn -- Yesterday, the Federal Circuit affirmed the determination by the District Court for the Southern District of New York that Defendants-Appellees Mylan Laboratories, Inc., Mylan Pharmaceuticals, Incorporated, Esteve Quimica, S.A., and Laboratorios Dr...
Will Biotechnology Solve the World Food Crisis?
Posted on June 12, 2008By Kevin E. Noonan -- The current crises in energy and food have followed eerily similar paths. The founding of OPEC and the exponential rise in crude oil prices during and after the 1973 Arab-Israeli conflict produced a short-lived emphasis in the U...
USPTO News: New Appeals Rules Published
Posted on June 11, 2008By Donald Zuhn -- As we reported yesterday, the U.S Patent and Trademark Office published a notice in the Federal Register today setting forth amended rules of practice before the Board of Patent Appeals and Interferences (BPAI) in ex parte appeals (new appeals rules)...
Court Report
Posted on June 09, 2008By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Lupin Limited et al. v. Sanofi-Aventis Deutschland GMBH et al. 2:08-cv-00258; filed June 5, 2008 in the Eastern District...
New Patent PDF Download Tool
Posted on June 09, 2008By Donald Zuhn -- Rolf Claessen, a patent attorney with Kreisler Selting Werner in Cologne, Germany, recently contacted Patent Docs to let us know about a new tool he is offering on his useful IP portal, IP Newsflash. The new tool, Free Patent PDF Download, allows patent practitioners to download...
USPTO News: Patent Office to Publish New Appeals Rules on Tuesday
Posted on June 09, 2008By Donald Zuhn -- The U.S. Patent and Trademark Office announced today that new rules regarding ex parte appeals before the Board of Patent Appeals and Interferences will be published in the Federal Register on Tuesday, June 10, 2008. According to the Office's press release, the new appeals rules "will...
Expresso: New Technology Search Engine
Posted on June 07, 2008By Donald Zuhn -- Dr. Michael Wisz, the Chief Technical Officer of Emerjent, Inc., recently contacted Patent Docs to inform us about Expresso, a new web-based search application that Emerjent is tauting as "the premier emerging technology information search engine...
Patent Office Catch-22
Posted on June 06, 2008By Kevin E. Noonan -- There was a time not so long ago where the U.S. Patent and Trademark Office seemed to be sincere in trying to accommodate the needs of inventors and the public in providing fair examination of cutting-edge technologies. This is particularly true in the biotechnology arts,...
Biotech/Pharma Lobbying Scoreboard
Posted on June 06, 2008By Donald Zuhn -- Last month, we reported on the lobbying expenditures for a number of biotech and pharmaceutical companies in the first quarter of 2008. Included on our list were Cephalon, Inc., which spent $512,000, Abbott Laboratories, which spent $880,000, and Amgen Inc...
Monsanto Moves to Address World Food Shortages
Posted on June 05, 2008By Kevin E. Noonan -- American opinion has finally turned in support of the idea that global warming, and ecological concerns in general, are relevant and important to themselves and their children (despite years of opposition, both formal and informal, from the current Administration and its fellow-travelers from energy corporations...
Second Viread® Patent Survives Reexamination
Posted on June 04, 2008By Donald Zuhn -- Yesterday, Gilead Sciences, Inc. announced that the U.S. Patent and Trademark Office had issued a Notice of Intent to Issue an Ex Parte Reexamination Certificate for U.S. Patent No. 5,922,695. The '695 patent became the second of Gilead's four Viread® (tenofovir disoproxil fumarate) patents to survive...
USPTO to Reexamine ExonHit Therapeutics Patent
Posted on June 03, 2008By Donald Zuhn -- Last month, Larkspur, California-based biotech Jivan Biologics, Inc. announced that the U.S. Patent and Trademark Office had granted its request for an ex parte reexamination of U.S. Patent No. 6,881,571, which is owned by ExonHit Therapeutics S...
Court Report
Posted on June 02, 2008By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Wyeth v. Sandoz Inc. 1:08-cv-00317; filed May 28, 2008 in the District Court of Delaware Infringement of U...
Conference & CLE Calendar
Posted on June 02, 2008June 4, 2008 - Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting (U.S. Patent and Trademark Office) June 11, 2008 - Advanced Patent Licensing 2008: What You Need to Know Before Licensing Your Patent (Practising Law Institute) - San Francisco, CA June 16, 2008 - Prior Art & Obviousness 2008: The PTO and CAFC...
Previous | Next
can you patent the idea of letting, for a proper price, adults direct a porn scene for there own possesion over the internet or in person? A scene witch will be a one of a kind and owned by them without the ability for r
Probably not, as it's already been done....
Should I copyright software I developed?
Depends on whether you are concerned that someone might make unauthorized copies...
Will vonage go bankrupt as a result of the Verizon patent suit over VOIP technology?
Vonage will most certainly be bankrupted if it doesn't sell itself first. I...
How does one get a patent?
Contact the patent office for your state or country (you can look this up throug...
Need urgent answer. Never signed Truth in Lending Disclosure docs - docs at closing had different terms and rates than what we had originally signed up for in the Loan Application. Signed closing docs as assured it would
you have three days to change your mind after closing a re-fi...

can you patent the idea of letting, for a proper price, adults direct a porn scene for there own possesion over the internet or in person? A scene witch will be a one of a kind and owned by them without the ability for r
Probably not, as it's already been done....
Should I copyright software I developed?
Depends on whether you are concerned that someone might make unauthorized copies...
Will vonage go bankrupt as a result of the Verizon patent suit over VOIP technology?
Vonage will most certainly be bankrupted if it doesn't sell itself first. I...
How does one get a patent?
Contact the patent office for your state or country (you can look this up throug...
Need urgent answer. Never signed Truth in Lending Disclosure docs - docs at closing had different terms and rates than what we had originally signed up for in the Loan Application. Signed closing docs as assured it would
you have three days to change your mind after closing a re-fi...








